EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:167904 - PJ34 hydrochloride
| Formula | C17H17N3O2.HCl |
| Net Charge | 0 |
| Average Mass | 331.803 |
| Monoisotopic Mass | 331.10875 |
| SMILES | CN(C)CC(=O)Nc1ccc2nc(=O)c3ccccc3c2c1.Cl |
| InChI | InChI=1S/C17H17N3O2.ClH/c1-20(2)10-16(21)18-11-7-8-15-14(9-11)12-5-3-4-6-13(12)17(22)19-15;/h3-9H,10H2,1-2H3,(H,18,21)(H,19,22);1H |
| InChIKey | RURAZZMDMNRXMI-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Roles: | apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor An EC 2.4.2.* (pentosyltransferase) inhibitor that interferes with the action of a NAD+ ADP-ribosyltransferase (EC 2.4.2.30). |
| Applications: | anti-inflammatory agent Any compound that has anti-inflammatory effects. cardioprotective agent Any protective agent that is able to prevent damage to the heart. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. angiogenesis inhibitor An agent and endogenous substances that antagonize or inhibit the development of new blood vessels. antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| PJ34 hydrochloride (CHEBI:167904) has part PJ34(1+) (CHEBI:167903) |
| PJ34 hydrochloride (CHEBI:167904) has role angiogenesis inhibitor (CHEBI:48422) |
| PJ34 hydrochloride (CHEBI:167904) has role anti-inflammatory agent (CHEBI:67079) |
| PJ34 hydrochloride (CHEBI:167904) has role antiatherosclerotic agent (CHEBI:145947) |
| PJ34 hydrochloride (CHEBI:167904) has role antineoplastic agent (CHEBI:35610) |
| PJ34 hydrochloride (CHEBI:167904) has role apoptosis inducer (CHEBI:68495) |
| PJ34 hydrochloride (CHEBI:167904) has role cardioprotective agent (CHEBI:77307) |
| PJ34 hydrochloride (CHEBI:167904) has role EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor (CHEBI:62913) |
| PJ34 hydrochloride (CHEBI:167904) has role neuroprotective agent (CHEBI:63726) |
| PJ34 hydrochloride (CHEBI:167904) is a hydrochloride (CHEBI:36807) |
| IUPAC Name |
|---|
| N2,N2-dimethyl-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)glycinamide hydrochloride |
| Synonyms | Source |
|---|---|
| 2-(dimethylamino)-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)acetamide hydrochloride | ChEBI |
| N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-(N,N-dimethylamino)acetamide hydrochloride | ChEBI |
| N,N-dimethyl-2-oxo-2-[(6-oxo-5,6-dihydrophenanthridin-2-yl)amino]ethan-1-aminium chloride | IUPAC |
| N,N-dimethyl-2-oxo-2-[(6-oxo-5,6-dihydrophenanthridin-2-yl)amino]ethanaminium chloride | IUPAC |
| N2,N2-dimethyl-N-(6-oxo-5,6-dihydrophenanthridin-2-yl)glycinamide—hydrogen chloride | IUPAC |
| PJ 34 HCl | ChEBI |
| Registry Numbers | Sources |
|---|---|
| CAS:344458-15-7 | ChEBI |
| Citations |
|---|